References

  1. Taboulet P. Anticoagulation d'une fibrillation auriculaire aux urgences. Ann Fr Médecine Urgence. 2012;2(5):317-22. PubMed | Google Scholar

  2. Ntep-Gweth M, Zimmermann M, Meiltz A et al. Atrial fibrillation in Africa: clinical characteristics, prognosis, and adherence to guidelines in Cameroon. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2010;12(4):482-7. PubMed | Google Scholar

  3. Bhagat K, Tisocki K. Prescribing patterns for the use of antithrombotics in the management of atrial fibrillation in Zimbabwe. Cent Afr J Med. 1999;45(11):287-90. PubMed | Google Scholar

  4. Meiltz A, Zimmermann M, Urban P et al. Atrial fibrillation management by practice cardiologists: a prospective survey on the adherence to guidelines in the real world. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2008;10(6):674-80. PubMed | Google Scholar

  5. Nieuwlaat R, Capucci A, Camm AJ et al. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J. 2005;26(22):2422-34. PubMed | Google Scholar

  6. Devereaux PJ, Anderson DR, Gardner MJ et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. BMJ. 2001;323(7323):1218-22. PubMed | Google Scholar

  7. Fang MC, Stafford RS, Ruskin JN et al. National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation. Arch Intern Med. 2004;164(1):55-60. PubMed | Google Scholar

  8. Go AS, Hylek EM, Borowsky LH et al. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med. 1999;131(12):927-34. PubMed | Google Scholar

  9. Lip GYH, Nieuwlaat R, Pisters R et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263-72. PubMed | Google Scholar

  10. Pisters R, Lane DA, Nieuwlaat R et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010;138(5):1093-100. PubMed | Google Scholar

  11. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(19):2369-429. PubMed | Google Scholar

  12. Davy JM, Roubille F, Tri Cung T et al. La fibrillation atriale en 2010: un poids croissant sur la morbidité et la mortalité cardiovasculaires. Ann Cardiol Angéiologie. 2010;59:S4-13. PubMed | Google Scholar

  13. Naccarelli GV, Panaccio MP, Cummins G et al. CHADS2 and CHA2DS2-VASc risk factors to predict first cardiovascular hospitalization among atrial fibrillation/atrial flutter patients. Am J Cardiol. 2012;109(10):1526-33. PubMed | Google Scholar

  14. Coulibaly I, Anzouan-Kacou JB, Konin KC et al. [Atrial fibrillation: epidemiological data from the Cardiology Institute in Abidjan, Côte d'Ivoire]. Médecine Trop Rev Corps Santé Colon. 2010;70(4):371-4. PubMed | Google Scholar

  15. Falk RH. Atrial fibrillation. N Engl J Med. 2001;344(14):1067-78. PubMed | Google Scholar

  16. Hart RG, Benavente O, McBride R et al. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med. 1999;131(7):492-501. PubMed | Google Scholar

  17. Hanon O. AVK et fibrillation atriale: quels bénéfices chez le sujet agé. Cah Annee Gerontol. 2010;2:523. PubMed | Google Scholar

  18. Fuller R, Dudley N, Blacktop J. Avoidance hierarchies and preferences for anticoagulation--semi-qualitative analysis of older patients' views about stroke prevention and the use of warfarin. Age Ageing. 2004;33(6):608-11. PubMed | Google Scholar

  19. Garcia D. Novel anticoagulants and the future of anticoagulation. Thromb Res. 2009;123 Suppl 4:S50-5. PubMed | Google Scholar

  20. Garcia DA. Benefits and risks of oral anticoagulation for stroke prevention in non valvular atrial fibrillation. Thromb Res. 2012;129(1):9-16. PubMed | Google Scholar